These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16313977)

  • 21. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
    Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
    Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
    Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
    J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.
    Cai Z; Zhang C; Chang KS; Jiang J; Ahn BC; Wakita T; Liang TJ; Luo G
    J Virol; 2005 Nov; 79(22):13963-73. PubMed ID: 16254332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
    Itsui Y; Sakamoto N; Kakinuma S; Nakagawa M; Sekine-Osajima Y; Tasaka-Fujita M; Nishimura-Sakurai Y; Suda G; Karakama Y; Mishima K; Yamamoto M; Watanabe T; Ueyama M; Funaoka Y; Azuma S; Watanabe M
    Hepatology; 2009 Dec; 50(6):1727-37. PubMed ID: 19821486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference of hepatitis C virus replication in cell culture by antisense peptide nucleic acids targeting the X-RNA.
    Ahn DG; Shim SB; Moon JE; Kim JH; Kim SJ; Oh JW
    J Viral Hepat; 2011 Jul; 18(7):e298-306. PubMed ID: 21692941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.
    Kumar D; Chaudhury I; Kar P; Das RH
    J Gastroenterol Hepatol; 2009 May; 24(5):872-8. PubMed ID: 19220662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
    Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
    J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells.
    Murayama A; Date T; Morikawa K; Akazawa D; Miyamoto M; Kaga M; Ishii K; Suzuki T; Kato T; Mizokami M; Wakita T
    J Virol; 2007 Aug; 81(15):8030-40. PubMed ID: 17522229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfection and expression of HCV-NS5B gene in Huh-7 cells.
    Fang J; Ouyang E; Wu CH; Wu GY; Qiu D; Xiao S
    Chin Med J (Engl); 2000 Jul; 113(7):602-5. PubMed ID: 11776027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
    Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
    Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
    Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.
    Chandra PK; Hazari S; Poat B; Gunduz F; Prabhu R; Liu G; Burioni R; Clementi M; Garry RF; Dash S
    Virol J; 2010 Jun; 7():118. PubMed ID: 20529250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.
    Shimakami T; Hijikata M; Luo H; Ma YY; Kaneko S; Shimotohno K; Murakami S
    J Virol; 2004 Mar; 78(6):2738-48. PubMed ID: 14990694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
    Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
    Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
    Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
    J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
    Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
    Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Construction and functional characterization of a monocistronic replicon based on the HCV genotype 2a promotor].
    Li XL; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):103-7. PubMed ID: 22464780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.